ITCAR

Serial Number 88906321
606

Registration Progress

Application Filed
May 8, 2020
Under Examination
Feb 9, 2021
Approved for Publication
Dec 15, 2020
Published for Opposition
Dec 15, 2020
Registered

Trademark Image

ITCAR

Basic Information

Serial Number
88906321
Filing Date
May 8, 2020
Published for Opposition
December 15, 2020
Abandonment Date
March 11, 2024
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Mar 11, 2024
Classes
005

Rights Holder

Allogene Therapeutics, Inc.

03
Address
210 E. Grand Avenue
South San Francisco, CA 94080

Ownership History

Allogene Therapeutics, Inc.

Original Applicant
03
South San Francisco, CA

Allogene Therapeutics, Inc.

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
Jason S. Howell

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

39 events
Date Code Type Description Documents
Mar 11, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 11, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 8, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 7, 2023 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 31, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 31, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 19, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 19, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 21, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 19, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 19, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 19, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 9, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 9, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 14, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 12, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 12, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 9, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 15, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 15, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 12, 2020 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Nov 10, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Nov 10, 2020 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 10, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 10, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 10, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 11, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 11, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 11, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 5, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 19, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 12, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005